Brokerage Firm Rating on Infosys Limited (INFY)

Infosys Limited (INFY) : Zacks Investment Research ranks Infosys Limited (INFY) as 4, which is a Sell recommendation. 2 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 10 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 12 research analysts is 2.67, which indicates as a Hold.

Infosys Limited (INFY) : 6 Wall Street analysts covering Infosys Limited (INFY) believe that the average level the stock could reach for the short term is $19.65. The maximum price target given is $21 and the minimum target for short term is around $18, hence the standard deviation is calculated at $1.03.


Company shares have received an average consensus rating of Hold for the current week Infosys Limited (NYSE:INFY): The stock opened at $16.38 on Thursday but the bulls could not build on the opening and the stock topped out at $16.51 for the day. The stock traded down to $16.33 during the day, due to lack of any buying support eventually closed down at $16.43 with a loss of -0.48% for the day. The stock had closed at $16.51 on the previous day. The total traded volume was 4,996,723 shares.

Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Companys solutions include application development and maintenance, independent validation services, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; Management Consulting, enterprise solutions and package implementation, systems integration and business intelligence; Products, business platforms and solutions, and technologies, such as cloud computing, enterprise mobility, digital, big data and analytics. Its segments are Financial Services and Insurance, Manufacturing, Energy and utilities, Communication and Services, Retail, Consumer packaged goods and Logistics, Life Sciences and Healthcare, and Growth Markets.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.